Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

malignancy

  • Open Access
    Loss of Malignancy of Super-Methotrexate-resistant Osteosarcoma Cells Is Associated With an Increase of Methylated Histone Marks H3K9me3 and H3K27me3
    YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research October 2024, 44 (10) 4213-4218; DOI: https://doi.org/10.21873/anticanres.17251
  • Open Access
    Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression
    YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research July 2024, 44 (7) 2787-2792; DOI: https://doi.org/10.21873/anticanres.17090
  • You have access
    Management of Soft-tissue Tumors With a Size of 2-5 cm, Including Malignancy
    YOSHIHIRO ARAKI, NORIO YAMAMOTO, TORU MAEDA, HIROAKI KIMURA, TAKASHI OTA, SHINGO SHIMOZAKI, TAKASHI KATO, DAISUKE INOUE, TAKASHI HIGUCHI, KENSAKU ABE, YUTA TANIGUCHI and HIROYUKI TSUCHIYA
    Anticancer Research March 2022, 42 (3) 1555-1562; DOI: https://doi.org/10.21873/anticanres.15629
  • You have access
    Determinative Structural Features Identified With Probe-based Confocal Endomicroscopy for the Accurate Diagnosis of Gallbladder Malignancy
    TOMOTAKE KOIZUMI, TAKESHI AOKI, TOSHIKO YAMOCHI, YOSHIHIKO TASHIRO, TATSUYA YAMAZAKI, TOMOKAZU KUSANO, KAZUHIRO MATSUDA, YUSUKE WADA, HIDEKI SHIBATA, KAZUHIKO SAITO, KOJI NOGAKI, TOMOKI HAKOZAKI, KODAI TOMIOKA, TAKAHITO HIRAI, AKIRA FUJIMORI, DOAA A. MANSOUR, AHMED ELEWA ABBAS GAHIN and ROBERT M. HOFFMAN
    Anticancer Research January 2022, 42 (1) 67-73; DOI: https://doi.org/10.21873/anticanres.15458
  • You have access
    Tumor Suppression in Asymptomatic Postmenopausal Endometrial Polyps
    LINA ADOMAITIENE, RUTA NADISAUSKIENE, MAHSHID NICKKHO-AMIRY, ARVYDAS CIZAUSKAS, JOLITA PALUBINSKIENE, CATHRINE HOLLAND and MOURAD W. SEIF
    Anticancer Research February 2020, 40 (2) 789-794; DOI: https://doi.org/10.21873/anticanres.14010
  • You have access
    Renin–Angiotensin Inhibition in Combating Malignancy: A Review
    TALMA ROSENTHAL and IRENE GAVRAS
    Anticancer Research September 2019, 39 (9) 4597-4602; DOI: https://doi.org/10.21873/anticanres.13639
  • You have access
    Frequency of Daily Tooth Brushing and Development of any Type of Malignancy
    DAIKI KOBAYASHI, OSAMU TAKAHASHI and TAKURO SHIMBO
    Anticancer Research August 2019, 39 (8) 4415-4421; DOI: https://doi.org/10.21873/anticanres.13613
  • You have access
    Demographical Profile and Spectrum of Multiple Malignancies in Children and Adults with Neurocutaneous Disorders
    AGATA MARJANSKA, AGNIESZKA JATCZAK-GACA, AGNIESZKA WOJTKIEWICZ, MARIUSZ WYSOCKI and JAN STYCZYNSKI
    Anticancer Research September 2018, 38 (9) 5453-5457; DOI: https://doi.org/10.21873/anticanres.12877
  • You have access
    Clinical Implications of Augmenter of Liver Regeneration in Cancer: A Systematic Review
    KEVIN H. NGUYEN, AUSTIN H. NGUYEN and DEEPA V. DABIR
    Anticancer Research July 2017, 37 (7) 3379-3383;
  • You have access
    Genome-wide Expression Profiling (with Focus on the Galectin Network) in Tumor, Transition Zone and Normal Tissue of Head and Neck Cancer: Marked Differences Between Individual Patients and the Site of Specimen Origin
    VERONIKA ZIVICOVA, PETR BROZ, ZDENEK FIK, ALZBETA MIFKOVA, JAN PLZAK, ZDENEK CADA, HERBERT KALTNER, JANA FIALOVA KUCEROVA, HANS-JOACHIM GABIUS and KAREL SMETANA
    Anticancer Research May 2017, 37 (5) 2275-2288;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire